Investing.com — 周二，H.C. Wainwright分析师Andrew Fein将Unity Biotechnology Inc (NASDAQ: UBX )的目标价从此前的8.00美元大幅下调至4.00美元，同时重申了该公司对该股的买入评级。此次调整是在Unity的药物候选者foselutoclax (UBX1325)用于治疗糖尿病黄斑水肿 ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that enhance therapeutic efficacy across oncology, autoimmune disorders, and ra | ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...